US BANCORP \DE\ - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$127,109
-50.3%
5,672
-9.7%
0.00%
Q2 2023$255,530
-37.2%
6,283
-25.3%
0.00%
-100.0%
Q1 2023$407,187
+37.7%
8,406
+8.5%
0.00%0.0%
Q4 2022$295,665
-28.9%
7,746
-6.5%
0.00%0.0%
Q3 2022$416,000
+15.9%
8,285
-7.4%
0.00%0.0%
Q2 2022$359,000
+4.1%
8,946
-3.4%
0.00%0.0%
Q1 2022$345,000
+2.7%
9,257
+9.9%
0.00%0.0%
Q4 2021$336,000
+25.4%
8,425
+16.9%
0.00%0.0%
Q3 2021$268,000
-4.6%
7,206
+8.2%
0.00%0.0%
Q2 2021$281,000
-2.4%
6,657
+9.7%
0.00%0.0%
Q1 2021$288,000
+1500.0%
6,069
+1909.6%
0.00%
Q4 2020$18,000
+350.0%
302
+251.2%
0.00%
Q3 2020$4,000
+300.0%
86
+207.1%
0.00%
Q2 2020$1,000
-98.8%
28
-98.5%
0.00%
Q2 2019$86,000
-26.5%
1,908
-38.7%
0.00%
Q1 2019$117,000
+19.4%
3,115
+9.3%
0.00%
Q4 2018$98,000
+10.1%
2,851
+50.6%
0.00%
Q3 2018$89,000
+53.4%
1,893
+9.2%
0.00%
Q2 2018$58,0001,733
+24657.1%
0.00%
Q1 2016$0
-100.0%
7
-99.0%
0.00%
Q3 2015$18,0006960.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders